p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

被引:1810
作者
Yang, AN
Kaghad, M
Wang, YM
Gillett, E
Fleming, MD
Dotsch, V
Andrews, NC
Caput, D
McKeon, F [2 ]
机构
[1] Sanofi Rech, F-31676 Labege, France
[2] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[3] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA
[4] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1097-2765(00)80275-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe the cloning of p63, a gene at chromosome 3q27-29 that bears strong homology to the tumor suppressor p53 and to the related gene, p73. p63 was detected in a variety of human and mouse tissues, including proliferating basal cells of epithelial layers in the epidermis, cervix, urothelium, and prostate. Unlike p53, the p63 gene encodes multiple isotypes with remarkably divergent abilities to transactivate p53 reporter genes and induce apoptosis. Importantly, the predominant p63 isotypes in many epithelial tissues lack an acidic N terminus corresponding to the transactivation domain of p53. We demonstrate that these truncated p63 variants can act as dominant-negative agents toward transactivation by p53 and p63, and we suggest the possibility of physiological interactions among members of the p53 family.
引用
收藏
页码:305 / 316
页数:12
相关论文
共 37 条
  • [1] Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79
  • [2] Bockmuhl U, 1996, CANCER RES, V56, P5325
  • [3] EVIDENCE FOR 2 TUMOR-SUPPRESSOR LOCI ON CHROMOSOMAL BANDS-1P35-36 INVOLVED IN NEUROBLASTOMA - ONE PROBABLY IMPRINTED, ANOTHER ASSOCIATED WITH N-MYC AMPLIFICATION
    CARON, H
    PETER, M
    VANSLUIS, P
    SPELEMAN, F
    DEKRAKER, J
    LAUREYS, G
    MICHON, J
    BRUGIERES, L
    VOUTE, PA
    WESTERVELD, A
    SLATER, R
    DELATTRE, O
    VERSTEEG, R
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (04) : 535 - 539
  • [4] CLONAL P53 MUTATION IN PRIMARY CERVICAL-CANCER - ASSOCIATION WITH HUMAN-PAPILLOMAVIRUS-NEGATIVE TUMORS
    CROOK, T
    WREDE, D
    TIDY, JA
    MASON, WP
    EVANS, DJ
    VOUSDEN, KH
    [J]. LANCET, 1992, 339 (8801) : 1070 - 1073
  • [5] A P53-DEPENDENT MOUSE SPINDLE CHECKPOINT
    CROSS, SM
    SANCHEZ, CA
    MORGAN, CA
    SCHIMKE, MK
    RAMEL, S
    IDZERDA, RL
    RASKIND, WH
    REID, BJ
    [J]. SCIENCE, 1995, 267 (5202) : 1353 - 1356
  • [6] MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL
    DENG, CX
    ZHANG, PM
    HARPER, JW
    ELLEDGE, SJ
    LEDER, P
    [J]. CELL, 1995, 82 (04) : 675 - 684
  • [7] GENOME-WIDE SEARCH FOR LOSS OF HETEROZYGOSITY IN TRANSGENIC MOUSE-TUMORS REVEALS CANDIDATE TUMOR-SUPPRESSOR GENES ON CHROMOSOME-9 AND CHROMOSOME-16
    DIETRICH, WF
    RADANY, EH
    SMITH, JS
    BISHOP, JM
    HANAHAN, D
    LANDER, ES
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9451 - 9455
  • [8] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [9] LOSS OF ALLELES FROM THE DISTAL SHORT ARM OF CHROMOSOME-1 OCCURS LATE IN MELANOMA TUMOR PROGRESSION
    DRACOPOLI, NC
    HARNETT, P
    BALE, SJ
    STANGER, BZ
    TUCKER, MA
    HOUSMAN, DE
    KEFFORD, RF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) : 4614 - 4618
  • [10] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825